Ambeed.cn

首页 / / / / Verteporfin/维替泊芬

Verteporfin/维替泊芬 {[allProObj[0].p_purity_real_show]}

货号:A138297 同义名: CL 318952; BPD-MA

Verteporfin, a benzoporphyrin derivative monoacid ring A, inhibits TEAD–YAP association and YAP-induced liver overgrowth. It is also a potent second-generation photosensitizing agent.

Verteporfin/维替泊芬 化学结构 CAS号:129497-78-5
Verteporfin/维替泊芬 化学结构
CAS号:129497-78-5
Verteporfin/维替泊芬 3D分子结构
CAS号:129497-78-5
Verteporfin/维替泊芬 化学结构 CAS号:129497-78-5
Verteporfin/维替泊芬 3D分子结构 CAS号:129497-78-5
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Verteporfin/维替泊芬 纯度/质量文件 产品仅供科研

货号:A138297 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

更多 >
产品名称 Autophagy 其他靶点 纯度
SBI-0206965 +++

ULK1, IC50: 108 nM

ULK2, IC50: 711 nM

95%
Hydroxychloroquine sulfate 99%
Valproic acid sodium HDAC 97%
PFK-015 ++

PFKFB3, IC50: 207 nM

99%+
MRT68921 HCl ++++

ULK1, IC50: 2.9 nM

ULK2, IC50: 1.1 nM

99%+
ROC-325 99%+
Autophinib +++

Autophagy, IC50: 40 nM

99%
Lys05 99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Verteporfin/维替泊芬 生物活性

靶点
  • VDA

描述 Verteporfin (CL 318952) is utilized as a photosensitizer in photodynamic therapy aimed at eradicating abnormal blood vessels in the eye, particularly in conditions like age-related macular degeneration. It also functions as a YAP inhibitor, effectively disrupting YAP-TEAD interactions and inducing apoptosis in cells[1]. Additionally, Verteporfin acts as an autophagy inhibitor, specifically blocking the early stages of autophagy by preventing autophagosome formation[3].

Verteporfin/维替泊芬 细胞研究

细胞系 浓度 检测类型 检测时间 活性说明 数据源
ARPE-19 ~0.1 μg/ml cytotoxicity assay shows a dose-dependent toxicity 16987905
ARPE-19 0.01 μg/ml Function assay increases VEGF and reduces PEDF expression 16987905
ARPE-19 0.5 µg/ml cytotoxicity assay decreases viability by 55.5% 23441114
BxPC-3 10 μM Growth inhibitory assay inhibits cell proliferation completely 24069069

Verteporfin/维替泊芬 动物研究

Animal study In vivo studies have demonstrated that Verteporfin, administered at 10 mg/kg through c.s.c., significantly reduces the leukemia cell ratio in combination with BMS-354825. This combined therapy further decreases the number of leukemia cells found in the spleen[1].
Pharmacokinetics
Animal Rats[6]
Dose 2 mg/kg
Administration i.v.
AUC0-inf 13.653 μg·h/ml (male)
12.628 μg·h/ml (female)
T1/2 7.12 h (male)
2.94 h (female)
Tmax 0.017 h (male)
0.017 h (female)
CL 2.44 ml/min/kg (male)
2.64 ml/min/kg (female)
Cmax 20.360 μg/ml (male)
25.203 μg/ml (female)
Vss 0.57 L/kg (male)
0.35 L/kg (female)
AUC0→t 9.297 μg·h/ml (male)
11.323 μg·h/ml (female)

Verteporfin/维替泊芬 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00211484 Age-Related Macular Degenerati... 展开 >>ons. Subfoveal Neovascularization. 收起 << Phase 2 Completed - United States, New York ... 展开 >> Manhattan Eye, Ear & Throat Hospital New York, New York, United States, 10021 收起 <<
NCT02587767 Acute Central Serous Chorioret... 展开 >>inopathy 收起 << Not Applicable Active, not recruiting December 2018 China, Guangdong ... 展开 >> Zhongshan Ophthalmic Center, Sun Yat-sen University Guangzhou, Guangdong, China, 510060 收起 <<
NCT02072408 Polypoidal Choroidal Vasculopa... 展开 >>thy Without Active Polyp 收起 << Phase 4 Completed - Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Seongnam, Gyunggi-do, Korea, Republic of Konyang University Kim's Eye Hospital Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of 收起 <<

Verteporfin/维替泊芬 参考文献

[1]Morishita T, et al. The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with BMS-354825. Oncotarget. 2016 Aug 2.

[2]Pan W, et al. Verteporfin can Reverse the NSC 125973 Resistance Induced by YAP Over-Expression in HCT-8/T Cells without Photoactivation through Inhibiting YAP Expression. Cell Physiol Biochem. 2016;39(2):481-90.

[3]Donohue E, et al. The autophagy inhibitor verteporfin moderately enhances the antitumor activity of gemcitabine in a pancreatic ductal adenocarcinoma model.J Cancer. 2013 Aug 28;4(7):585-96.

Verteporfin/维替泊芬 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.39mL

0.28mL

0.14mL

6.96mL

1.39mL

0.70mL

13.91mL

2.78mL

1.39mL

Verteporfin/维替泊芬 技术信息

CAS号129497-78-5
分子式C41H42N4O8
分子量 718.79
SMILES Code NONE
MDL No. MFCD28098202
别名 CL 318952; BPD-MA; DB00460, CL 318952, BPD-MA, BpdMA, Benzoporphyrin D, Benzoporphyrin derivative monoacid ring A, Verteporfin, Visudyne.
运输蓝冰
存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。